Filter your results
- 2
- 1
- 3
- 3
- 1
- 1
- 1
- 3
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 3
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance dataThe Lancet Digital Health, 2021, 3 (6), pp.e360-e370. ⟨10.1016/S2589-7500(21)00077-7⟩
Journal articles
pasteur-03261492v1
|
||
|
Small molecule inhibitors of the Yersinia type III secretion system impair the development of Chlamydia after entry into host cells.BMC Microbiology, 2009, 9, pp.75. ⟨10.1186/1471-2180-9-75⟩
Journal articles
pasteur-00409865v1
|
||
|
Identification of a family of effectors secreted by the type III secretion system that are conserved in pathogenic Chlamydiae.Infection and Immunity, 2011, 79 (2), pp.571-80. ⟨10.1128/IAI.00825-10⟩
Journal articles
pasteur-00568001v1
|